NCT02051452

Brief Summary

The aim of this study is to investigate whether methylphenidate (Ritalin) can actively induce emergence from general anesthesia in patients having a pancreaticoduodenectomy (Whipple procedure), a pancreatectomy, or a prostatectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Nov 2014

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 31, 2014

Completed
9 months until next milestone

Study Start

First participant enrolled

November 1, 2014

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

August 22, 2019

Completed
Last Updated

August 22, 2019

Status Verified

August 1, 2019

Enrollment Period

3.5 years

First QC Date

January 28, 2014

Results QC Date

April 25, 2019

Last Update Submit

August 21, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Adverse Events

    Recorded as a measure of safety and tolerability

    12 months

Secondary Outcomes (1)

  • Time to Emergence From General Anesthesia

    1-4 hours

Other Outcomes (1)

  • Post Operative Cognitive Function at ½ Hour, 1 Hour and 2 Hours After Emergence as Measured by the Mini Mental Status Exam.

    up to 4 hours

Study Arms (2)

Methylphenidate

EXPERIMENTAL

Methylphenidate

Drug: Methylphenidate

placebo

PLACEBO COMPARATOR

Saline

Other: Saline

Interventions

Also known as: ritalin
Methylphenidate
SalineOTHER
placebo

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-75 years
  • American Society of Anesthesiologists classification 1 or 2
  • Scheduled to undergo a pancreaticoduodenectomy or distal pancreatectomy at Massachusetts General Hospital

You may not qualify if:

  • American Society of Anesthesiologists physical status classification of 3 or beyond.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Interventions

MethylphenidateSodium Chloride

Intervention Hierarchy (Ancestors)

PhenylacetatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Results Point of Contact

Title
Dr. Ken Solt, MD, Associate Professor of Anaesthesia
Organization
Harvard Medical School

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Anesthesia

Study Record Dates

First Submitted

January 28, 2014

First Posted

January 31, 2014

Study Start

November 1, 2014

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

August 22, 2019

Results First Posted

August 22, 2019

Record last verified: 2019-08

Locations